Rein Therapeutics, Inc.
RNTX
1 insider filing · Latest: Apr 30, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | May 13 12:47 PM | James Brian WindsorDirector, President and Chief Executive Officer | Purchase | 25,000 | $1.00 | $25.0K | 27,046(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 8, 2026 | May 13 12:47 PM | James Brian WindsorDirector, President and Chief Executive Officer | Grant/Award | 150,000 | $1.17 | 150,000(D) | View → |